What is Silicon Labs's earnings per share (EPS)?

Silicon Labs (SLAB) reported diluted earnings per share of $-1.98 for fiscal year 2026. This represents a 66.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Silicon Labs Financials

SLAB

Source SEC Filings (10-K/10-Q) Data as of Apr 4, 2026 Currency USD FYE January

This page shows Silicon Labs (SLAB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SLAB FY2026 2026-05-05

Recovered product margins are being outweighed by deliberately high R&D spending, while cash flow has already turned back positive.

Operating cash flow moved from -$13.9M to $95.7M even though net income stayed negative. Because inventory ended lower while revenue recovered, the first sign of healing showed up in cash conversion rather than reported earnings, consistent with an asset-light operating model whose main reinvestment need is engineering, not factories.

Gross margin returned to 58.2% while operating margin was still -9.0%, implying the product economics recovered faster than the expense base. That gap points to sustained R&D intensity as the main drag on profit, so current losses are being created below gross profit rather than by weak unit economics.

The balance sheet is liability-light: cash of $364M exceeds total liabilities of $175M. That leaves the company funding its reset from internal liquidity instead of balance-sheet strain, which reduces the odds that near-term operating pressure turns into a financing problem.

Financial Health Signals

Financial Health Score 77/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Silicon Labs's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Altman Z-Score Safe

27.53

Silicon Labs scores 27.53, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($7.2B) relative to total liabilities ($167.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

Silicon Labs passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-1.47x

For every $1 of reported earnings, Silicon Labs generates $-1.47 in operating cash flow ($95.7M OCF vs -$64.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-72.3x

Silicon Labs earns $-72.3 in operating income for every $1 of interest expense (-$70.5M vs $975K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$784.8M

YoY+34.3%

5Y CAGR+9.0%

10Y CAGR+2.0%

Silicon Labs generated $784.8M in revenue in fiscal year 2026. This represents an increase of 34.3% from the prior year.

EBITDA

-$32.5M

YoY+72.2%

Silicon Labs's EBITDA was -$32.5M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 72.2% from the prior year.

Net Income

-$64.9M

YoY+66.0%

Silicon Labs reported -$64.9M in net income in fiscal year 2026. This represents an increase of 66.0% from the prior year.

EPS (Diluted)

$-1.98

YoY+66.6%

Silicon Labs earned $-1.98 per diluted share (EPS) in fiscal year 2026. This represents an increase of 66.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$65.8M

YoY+356.4%

5Y CAGR-11.0%

10Y CAGR-3.5%

Silicon Labs generated $65.8M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 356.4% from the prior year.

Cash & Debt

$383.1M

YoY+36.0%

5Y CAGR+13.3%

10Y CAGR+11.7%

Silicon Labs held $383.1M in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share

N/A

Shares Outstanding

33M

YoY+1.6%

5Y CAGR-5.9%

10Y CAGR-2.3%

Silicon Labs had 33M shares outstanding in fiscal year 2026. This represents an increase of 1.6% from the prior year.

Margins & Returns

Gross Margin

58.2%

YoY+4.8pp

5Y CAGR+0.5pp

10Y CAGR-0.8pp

Silicon Labs's gross margin was 58.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 4.8 percentage points from the prior year.

Operating Margin

-9.0%

YoY+19.3pp

5Y CAGR+12.0pp

10Y CAGR-14.0pp

Silicon Labs's operating margin was -9.0% in fiscal year 2026, reflecting core business profitability. This is up 19.3 percentage points from the prior year.

Net Margin

-8.3%

YoY+24.4pp

5Y CAGR-10.7pp

10Y CAGR-12.9pp

Silicon Labs's net profit margin was -8.3% in fiscal year 2026, showing the share of revenue converted to profit. This is up 24.4 percentage points from the prior year.

Return on Equity

-5.9%

YoY+11.8pp

5Y CAGR-7.0pp

10Y CAGR-9.9pp

Silicon Labs's ROE was -5.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 11.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$353.2M

YoY+6.3%

5Y CAGR+8.5%

10Y CAGR+6.5%

Silicon Labs invested $353.2M in research and development in fiscal year 2026. This represents an increase of 6.3% from the prior year.

Share Buybacks

YoY-100.0%

Silicon Labs spent $0 on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$29.9M

YoY+154.7%

5Y CAGR+10.6%

10Y CAGR+10.3%

Silicon Labs invested $29.9M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 154.7% from the prior year.

SLAB Income Statement

Metric	FY26	FY24	FY23	FY22	FY22	FY21
Revenue	$784.8M+34.3%	$584.4M-25.3%	$782.3M-23.6%	$1.0B+42.1%	$720.9M+41.1%	$510.9M
Cost of Revenue	$327.8M+20.4%	$272.2M-15.4%	$321.7M-15.7%	$381.5M+29.1%	$295.5M+36.7%	$216.1M
Gross Profit	$457.0M+46.4%	$312.2M-32.2%	$460.6M-28.3%	$642.6M+51.1%	$425.4M+44.3%	$294.8M
R&D Expenses	$353.2M+6.3%	$332.2M-1.6%	$337.7M+1.6%	$332.3M+21.6%	$273.2M+16.2%	$235.2M
SG&A Expenses	$174.3M+19.8%	$145.5M-1.0%	$147.0M-23.0%	$191.0M+3.2%	$185.0M+11.0%	$166.7M
Operating Income	-$70.5M+57.4%	-$165.5M-585.1%	-$24.2M-120.3%	$119.3M+463.2%	-$32.8M+69.3%	-$107.1M
Interest Expense	$975K-25.6%	$1.3M-76.4%	$5.6M-17.4%	$6.7M-78.3%	$31.0M-9.1%	$34.1M
Income Tax	$7.0M-80.7%	$36.2M+355.7%	$7.9M-79.3%	$38.5M+186.4%	$13.4M+192.0%	-$14.6M
Net Income	-$64.9M+66.0%	-$191.0M-453.4%	-$34.5M-137.8%	$91.4M-95.7%	$2.1B+16797.3%	$12.5M
EPS (Diluted)	$-1.98+66.6%	$-5.93-444.0%	$-1.09-142.9%	$2.54-94.7%	$47.78+16964.3%	$0.28

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Revenue	$213.5M+2.5%	$208.2M+1.1%	$206.0M+6.8%	$192.8M+8.5%	$177.7M+6.9%	$166.2M-0.1%	$166.4M+14.5%	$145.4M
Cost of Revenue	$86.5M+13.6%	$76.1M-12.5%	$87.0M+2.6%	$84.7M+6.0%	$79.9M+5.1%	$76.0M-0.1%	$76.1M+10.6%	$68.8M
Gross Profit	$127.0M-3.8%	$132.1M+11.0%	$119.0M+10.1%	$108.1M+10.6%	$97.8M+8.4%	$90.2M-0.1%	$90.3M+17.9%	$76.6M
R&D Expenses	$88.6M-1.0%	$89.5M+2.1%	$87.7M-0.2%	$87.8M-0.5%	$88.2M+7.0%	$82.4M-0.9%	$83.2M-3.1%	$85.9M
SG&A Expenses	$55.5M+21.1%	$45.8M+4.9%	$43.7M+1.2%	$43.2M+3.6%	$41.6M+14.4%	$36.4M-1.0%	$36.8M-4.9%	$38.7M
Operating Income	-$17.1M-425.3%	-$3.3M+73.7%	-$12.3M+46.0%	-$22.9M+28.7%	-$32.1M-12.1%	-$28.6M+3.6%	-$29.7M+38.1%	-$48.0M
Interest Expense	$232K+8.4%	$214K-5.3%	$226K-10.0%	$251K-11.6%	$284K+9.2%	$260K-6.5%	$278K+5.7%	$263K
Income Tax	$2.2M+2.7%	$2.1M+419.3%	$414K-83.6%	$2.5M+33.3%	$1.9M+191.0%	-$2.1M-204.0%	$2.0M-94.5%	$36.7M
Net Income	-$15.9M-492.3%	-$2.7M+73.0%	-$9.9M+54.5%	-$21.8M+28.4%	-$30.5M-27.9%	-$23.8M+16.4%	-$28.5M+65.3%	-$82.2M
EPS (Diluted)	$-0.48	N/A	$-0.30+55.2%	$-0.67+28.7%	$-0.94	N/A	$-0.88+65.6%	$-2.56

SLAB Balance Sheet

Metric	FY26	FY24	FY23	FY22	FY22	FY21
Total Assets	$1.3B+3.6%	$1.2B-15.3%	$1.4B-33.5%	$2.2B-23.7%	$2.8B+52.0%	$1.9B
Current Assets	$676.3M+12.3%	$602.0M-18.4%	$737.9M-49.5%	$1.5B-31.2%	$2.1B+146.6%	$860.9M
Cash & Equivalents	$383.1M+36.0%	$281.6M+23.8%	$227.5M-54.5%	$499.9M-34.7%	$765.9M+273.2%	$205.2M
Inventory	$103.2M-2.3%	$105.6M-45.6%	$194.3M+93.5%	$100.4M+80.9%	$55.5M-29.9%	$79.2M
Accounts Receivable	$77.1M+41.6%	$54.5M+86.0%	$29.3M-59.0%	$71.4M-9.8%	$79.2M-23.6%	$103.7M
Goodwill	$376.4M0.0%	$376.4M0.0%	$376.4M0.0%	$376.4M0.0%	$376.4M-40.4%	$631.9M
Total Liabilities	$167.9M+17.7%	$142.7M-39.1%	$234.4M-69.3%	$764.4M-8.6%	$836.1M+26.0%	$663.6M
Current Liabilities	$132.5M+35.3%	$97.9M-40.2%	$163.6M-12.0%	$185.8M-24.5%	$246.2M+63.3%	$150.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.1B+1.7%	$1.1B-10.6%	$1.2B-14.0%	$1.4B-30.0%	$2.0B+66.3%	$1.2B
Retained Earnings	$920.9M-8.1%	$1.0B-16.0%	$1.2B-15.7%	$1.4B-29.9%	$2.0B+100.4%	$1.0B

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Total Assets	$1.3B-0.2%	$1.3B+1.3%	$1.3B+2.6%	$1.2B-0.7%	$1.2B+0.6%	$1.2B-2.1%	$1.2B-0.1%	$1.2B
Current Assets	$676.3M+0.3%	$674.0M+3.3%	$652.6M+5.6%	$617.7M-0.1%	$618.7M+2.8%	$602.0M-2.0%	$614.1M+2.3%	$600.0M
Cash & Equivalents	$383.1M+5.2%	$364.2M+6.7%	$341.4M+8.6%	$314.5M-3.2%	$324.9M+15.4%	$281.6M-7.1%	$303.1M+25.8%	$240.8M
Inventory	$103.2M+8.0%	$95.6M+16.3%	$82.2M+1.6%	$80.9M-3.0%	$83.4M-21.1%	$105.6M-24.3%	$139.5M-16.0%	$166.1M
Accounts Receivable	$77.1M+19.5%	$64.5M-4.2%	$67.3M+19.1%	$56.5M+8.5%	$52.1M-4.4%	$54.5M+11.5%	$48.9M+18.6%	$41.2M
Goodwill	$376.4M0.0%	$376.4M0.0%	$376.4M0.0%	$376.4M0.0%	$376.4M0.0%	$376.4M0.0%	$376.4M0.0%	$376.4M
Total Liabilities	$167.9M-4.0%	$174.9M-4.1%	$182.4M+14.0%	$160.0M-0.7%	$161.1M+12.9%	$142.7M-15.0%	$167.9M+6.9%	$157.0M
Current Liabilities	$132.5M-7.9%	$143.8M-1.0%	$145.3M+20.4%	$120.7M+0.8%	$119.7M+22.3%	$97.9M-17.3%	$118.3M+18.2%	$100.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.1B+0.4%	$1.1B+2.2%	$1.1B+0.9%	$1.1B-0.7%	$1.1B-1.1%	$1.1B-0.1%	$1.1B-1.1%	$1.1B
Retained Earnings	$920.9M-1.7%	$936.8M-0.3%	$939.5M-1.0%	$949.4M-2.2%	$971.3M-3.0%	$1.0B-2.3%	$1.0B-2.7%	$1.1B

SLAB Cash Flow Statement

Metric	FY26	FY24	FY23	FY22	FY22	FY21
Operating Cash Flow	$95.7M+788.1%	-$13.9M+54.2%	-$30.3M-121.5%	$141.3M+54.9%	$91.2M-32.8%	$135.7M
Capital Expenditures	$29.9M+154.7%	$11.7M-47.3%	$22.3M-16.0%	$26.5M-7.2%	$28.6M+58.0%	$18.1M
Free Cash Flow	$65.8M+356.4%	-$25.7M+51.2%	-$52.6M-145.9%	$114.7M+83.2%	$62.6M-46.8%	$117.6M
Investing Cash Flow	-$12.0M-110.6%	$113.1M-75.9%	$469.8M+95.3%	$240.5M	N/A	-$361.0M
Financing Cash Flow	-$1.1M+97.6%	-$45.1M+93.7%	-$711.9M+19.7%	-$887.1M+31.7%	-$1.3B-746.5%	$200.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$16K-100.0%	$217.1M-75.4%	$883.4M-23.2%	$1.2B+6961.1%	$16.3M

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Operating Cash Flow	$4.9M-40.9%	$8.3M-75.7%	$34.3M+599.3%	$4.9M-89.8%	$48.1M+375.2%	$10.1M-68.0%	$31.6M+96.0%	$16.1M
Capital Expenditures	$9.8M-1.4%	$10.0M+56.1%	$6.4M-26.5%	$8.7M+79.2%	$4.9M+22.4%	$4.0M+79.5%	$2.2M-37.5%	$3.5M
Free Cash Flow	-$4.9M-200.8%	-$1.6M-105.8%	$27.9M+837.1%	-$3.8M-108.8%	$43.3M+601.8%	$6.2M-79.0%	$29.4M+133.4%	$12.6M
Investing Cash Flow	$14.9M+69.6%	$8.8M+230.0%	-$6.8M+33.5%	-$10.2M-160.3%	-$3.9M+89.8%	-$38.2M-226.4%	$30.2M-23.8%	$39.6M
Financing Cash Flow	-$956K-116.8%	$5.7M+1007.8%	-$627K+87.9%	-$5.2M-440.2%	-$958K-114.6%	$6.6M+1455.1%	$423K+106.6%	-$6.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$16K	$0	$0

SLAB Financial Ratios

Metric	FY26	FY24	FY23	FY22	FY22	FY21
Gross Margin	58.2%+4.8pp	53.4%-5.5pp	58.9%-3.9pp	62.7%+3.7pp	59.0%+1.3pp	57.7%
Operating Margin	-9.0%+19.3pp	-28.3%-25.2pp	-3.1%-14.7pp	11.7%+16.2pp	-4.6%+16.4pp	-21.0%
Net Margin	-8.3%+24.4pp	-32.7%-28.3pp	-4.4%-13.3pp	8.9%-284.8pp	293.7%+291.3pp	2.5%
Return on Equity	-5.9%+11.8pp	-17.7%-14.8pp	-2.9%-9.4pp	6.5%-99.0pp	105.5%+104.4pp	1.0%
Return on Assets	-5.1%+10.5pp	-15.6%-13.2pp	-2.4%-6.6pp	4.2%-70.3pp	74.5%+73.8pp	0.7%
Current Ratio	5.11-1.0	6.15+1.6	4.51-3.4	7.87-0.8	8.62+2.9	5.71
Debt-to-Equity	0.15+0.0	0.13-0.1	0.19-0.4	0.54+0.1	0.42-0.1	0.55
FCF Margin	8.4%+12.8pp	-4.4%+2.3pp	-6.7%-17.9pp	11.2%+2.5pp	8.7%-14.3pp	23.0%

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Gross Margin	59.5%-4.0pp	63.4%+5.7pp	57.8%+1.7pp	56.1%+1.0pp	55.0%+0.8pp	54.3%0.0pp	54.3%+1.6pp	52.7%
Operating Margin	-8.0%-6.4pp	-1.6%+4.4pp	-6.0%+5.9pp	-11.9%+6.2pp	-18.1%-0.8pp	-17.2%+0.6pp	-17.8%+15.2pp	-33.0%
Net Margin	-7.4%-6.2pp	-1.3%+3.5pp	-4.8%+6.5pp	-11.3%+5.8pp	-17.2%-2.8pp	-14.3%+2.8pp	-17.1%+39.4pp	-56.5%
Return on Equity	-1.5%-1.2pp	-0.2%+0.7pp	-0.9%+1.1pp	-2.1%+0.8pp	-2.9%-0.6pp	-2.2%+0.4pp	-2.6%+4.9pp	-7.5%
Return on Assets	-1.3%-1.1pp	-0.2%+0.6pp	-0.8%+1.0pp	-1.8%+0.7pp	-2.5%-0.5pp	-1.9%+0.3pp	-2.3%+4.3pp	-6.6%
Current Ratio	5.11+0.4	4.69+0.2	4.49-0.6	5.12-0.0	5.17-1.0	6.15+1.0	5.19-0.8	5.99
Debt-to-Equity	0.150.0	0.16-0.0	0.17+0.0	0.150.0	0.15+0.0	0.13-0.0	0.16+0.0	0.14
FCF Margin	-2.3%-1.5pp	-0.8%-14.3pp	13.6%+15.5pp	-2.0%-26.3pp	24.3%+20.6pp	3.7%-14.0pp	17.7%+9.0pp	8.7%

Similar Companies

Semtech SMTC

$11.7B

Allegro Microsystems, Inc. ALGM

$8.6B

Cirrus Logic Inc CRUS

$6.7B

Impinj Inc PI

$3.9B

Synaptics Inc SYNA

$4.4B

Frequently Asked Questions

What is Silicon Labs's annual revenue?

Silicon Labs (SLAB) reported $784.8M in total revenue for fiscal year 2026. This represents a 34.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Silicon Labs's revenue growing?

Silicon Labs (SLAB) revenue grew by 34.3% year-over-year, from $584.4M to $784.8M in fiscal year 2026.

Is Silicon Labs profitable?

No, Silicon Labs (SLAB) reported a net income of -$64.9M in fiscal year 2026, with a net profit margin of -8.3%.

What is Silicon Labs's EBITDA?

Silicon Labs (SLAB) had EBITDA of -$32.5M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Silicon Labs's gross margin?

Silicon Labs (SLAB) had a gross margin of 58.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Silicon Labs's operating margin?

Silicon Labs (SLAB) had an operating margin of -9.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Silicon Labs's net profit margin?

Silicon Labs (SLAB) had a net profit margin of -8.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Silicon Labs's return on equity (ROE)?

Silicon Labs (SLAB) has a return on equity of -5.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Silicon Labs's free cash flow?

Silicon Labs (SLAB) generated $65.8M in free cash flow during fiscal year 2026. This represents a 356.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Silicon Labs's operating cash flow?

Silicon Labs (SLAB) generated $95.7M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Silicon Labs's total assets?

Silicon Labs (SLAB) had $1.3B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Silicon Labs's capital expenditures?

Silicon Labs (SLAB) invested $29.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Silicon Labs spend on research and development?

Silicon Labs (SLAB) invested $353.2M in research and development during fiscal year 2026.

How many shares does Silicon Labs have outstanding?

Silicon Labs (SLAB) had 33M shares outstanding as of fiscal year 2026.

What is Silicon Labs's current ratio?

Silicon Labs (SLAB) had a current ratio of 5.11 as of fiscal year 2026, which is generally considered healthy.

What is Silicon Labs's debt-to-equity ratio?

Silicon Labs (SLAB) had a debt-to-equity ratio of 0.15 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Silicon Labs's return on assets (ROA)?

Silicon Labs (SLAB) had a return on assets of -5.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Silicon Labs's Altman Z-Score?

Silicon Labs (SLAB) has an Altman Z-Score of 27.53, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Silicon Labs's Piotroski F-Score?

Silicon Labs (SLAB) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Silicon Labs's earnings high quality?

Silicon Labs (SLAB) has an earnings quality ratio of -1.47x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Silicon Labs cover its interest payments?

Silicon Labs (SLAB) has an interest coverage ratio of -72.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Silicon Labs?

Silicon Labs (SLAB) scores 77 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.